Cegedim : CA consolidé Présentation du Chiffre d’Affaires du T1 2020 En savoir plus
April 27, 2020 at 11:58 am EDT
Share
This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on expectations and assumptions that we believe to be reasonable when made, but that may not prove to be accurate. By their nature, forward-looking statements involve risk and uncertainty. Consequently the company cannot guarantee their accuracy and their completeness, and actual results may differ materially from those the company anticipated due to a number of uncertainties, many of which the company is not aware of.
For additional information concerning important factors that may cause the company's actual results to differ materially from expectations and underlying assumptions, please refer to the reports filed by the company with the 'Autorité des Marchés Financiers'.
Any forward-looking statement speaks only as of the date on which it is made, and we assume no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by law.
3
The Big Picture
FY 2019
4
Finance
Q1 2020 Revenue overview
6
Strong BPO trend
7
LFL Q1 2020 revenue growth by business group
8
Health Insurance, HR & E-Services Division Overview
9
Healthcare Professionals Division Overview
Covid-19 Pandemic
11
FY 2020 Outlook
12
FY 2020 Financial Agenda
13
Annexes
Q1 2020 Revenue
In € thousands
Division 1
Division 2
Division 3
Group
2019 REVENUE (a)
79,239
39,100
882
119,222
Impact of disposals
0
(2,806)
0
(2,806)
2019 Revenue before impact of disposals
79,239
36,294
882
116,415
Currency impact
22
91
0
113
2019 Revenue at 2020 exchange rate (b)
79,261
36,386
882
116,529
2020 Revenue before impact of acquisition (c)
81,639
37,977
852
120,467
Revenue from acquisitions
1,029
0
0
1,029
2020 Revenue
82,667
37,977
852
121,496
Organic growth ([c-b/a]
+3.0%
+4.1%
(3.4)%
+3.3%
15
Thank you for your attention
Jan Eryk Umiastowski
Chief Investment Officer - Head of Investor Relations
Cegedim SA published this content on 27 April 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 April 2020 15:57:12 UTC
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows:
- Insurance companies and services (72.1%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS);
- Health care professionals (26.8%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.;
- other (1.1%).
France accounts for 89.7% of net sales.
CEGEDIM 
